Effector Therapeutics Competitors and Similar CompaniesClear all
Effector Therapeutics's competitors and similar companies include ImmunoGen and Aptevo Therapeutics.
 Effector Therapeutics Effector Therapeutics is a company focused on the discovery and development of small molecule cancer therapeutics. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. | |
Founding Date | Founding Date 2012 | Founding Date 1981 | Founding Date 2016 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Solana Beach, US HQ San Diego, US | Locations Waltham, US HQ | Locations Seattle, US HQ |
Employees | Employees 27 | Employees 277161% increase | Employees 1182% decrease |
Valuation ($) | Valuation ($) 1.9 k | Valuation ($) 8.7 b | Valuation ($) 4.1 m |
Financial | |||
Net income | Net income ($35.8m) (FY, 2023) | Net income ($222.9m) (FY, 2022) | Net income ($26m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 101m | Total funding raised $ 56m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View companyAptevo Therapeutics
HQ
Seattle, US
Employees
118↓ 2% decrease
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
View company